Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma.
Histopathology
; 79(5): 826-835, 2021 Nov.
Article
in En
| MEDLINE
| ID: mdl-34121230
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Tumor Suppressor Protein p53
/
CD8-Positive T-Lymphocytes
/
Neoadjuvant Therapy
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Histopathology
Year:
2021
Type:
Article
Affiliation country:
United States